Patent details
LUC50047 Product Name: brensocatib ou ses sels, ses hydrates ou les hydrates de ses sels, y compris le brensocatib monohydraté
Basic Information
- Publication number:
- LUC50047
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP157015777
- Legal Status:
- Pending & Published
- Application number:
- LUC50047
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/25/1995/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 19/11/2025
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 26/03/2026
- First Marketing Authorization date:
- 19/11/2025
- Grant date:
- Activation date:
- Publication date:
- 27/03/2026
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/01/2040
- SPC Extension Expiration:
- 23/01/2040
- Rejection date:
- Withdrawal date:
Owner
- From:
- 26/03/2026
- Name:
- Astrazeneca AB
- Address:
- Forskargatan 18, 151 85 Södertälje, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/03/2026
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|---|---|
| 26/03/2026 | Application Form | 5 |
| 26/03/2026 | Outgoing Correspondence | 2 |
| 26/03/2026 | General Document | 24 |
| 26/03/2026 | General Document | 1 |
| 26/03/2026 | General Document | 13 |
| 26/03/2026 | General Document | 3 |
| 27/03/2026 | Outgoing Correspondence | 1 |